Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753243 | 12675324 | 3 | F | 20160909 | 20160822 | 20160916 | EXP | GB-MHRA-EYC 00143803 | GB-009507513-1608GBR010246 | MERCK | 99.00 | YR | F | Y | 70.00000 | KG | 20160916 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753243 | 12675324 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 MG, QD, 20MG BUT INCREASED IN DAYS PRIOR TO HOSPITAL ADMISSION TO 60MG DAILY | Y | U | 70017 | 60 | MG | TABLET | QD | ||||
| 126753243 | 12675324 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD BUT INCREASED IN DAYS PRIOR TO HOSPITAL ADMISSION TO 60MG DAILY | Y | U | 70017 | 20 | MG | TABLET | QD | ||||
| 126753243 | 12675324 | 3 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 15 MG, QD | U | U | 0 | 15 | MG | STANDARD SOLUTION | QD | ||||
| 126753243 | 12675324 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG | CAPSULE | QD | ||||
| 126753243 | 12675324 | 5 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 12.5 MG, QD | U | U | 0 | QD | |||||||
| 126753243 | 12675324 | 6 | C | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126753243 | 12675324 | 7 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Respiratory (inhalation) | 0 | TABLET | ||||||||||
| 126753243 | 12675324 | 8 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 0 | INHALATION VAPOUR, SOLUTION | ||||||||||
| 126753243 | 12675324 | 9 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 126753243 | 12675324 | 10 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126753243 | 12675324 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126753243 | 12675324 | Acute kidney injury | |
| 126753243 | 12675324 | Confusional state | |
| 126753243 | 12675324 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |